Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P73
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kansy, Benjamin A
Lin, Yan
Ding, Fei
Gibson, Sandra Poveda
Jie, Hyun-Bae
Ferris, Robert L
Article History
First Online: 4 November 2015